By Thomas Wicks, Head of Data and Partnerships, Citeline
The world of clinical trial enforcement is evolving. The past three years have presented the pharmaceutical industry with unprecedented challenges and opportunities. Equipped with new experience and a fresh perspective, we are excited to take a thoughtful look into the future of the clinical trial compliance industry to see what lies ahead for sponsors.
New government disclosure regulations are emerging, emphasizing patient awareness and medical transparency — and necessitating greater administrative paperwork. Fortunately, these new requirements do not relegate pharmaceutical companies to chaos or noncompliance. Staying aware of arising regulations is one fundamental way to get ahead — and ease the burden of comprehensive global compliance.